Cooley represented Immunovant, while Latham & Watkins represented the underwriters in the offering. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Canoo, while Davis Polk advised the sales agents in the offering. Canoo, Inc. executed its at-the-market offering of shares of its common stock for...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Marathon Digital, while Latham & Watkins represented the initial purchasers in the offering. Marathon Digital Holdings, Inc., one of the largest enterprise Bitcoin...
You must be a Standard 1 Year member to access this content.
Edwin Coe has advised H.C. Wainwright & Co. on the matter. H.C. Wainwright & Co. acted as placement agent in a private placement of 41.5m of Eurasia Mining...
You must be a Standard 1 Year member to access this content.
Pestalozzi advised H.C. Wainwright on the deal. Homburger advised Santhera. Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular...
You must be a Standard 1 Year member to access this content.
Sichenzia Ross Ference represented H.C. Wainwright & Co., LLC as exclusive placement agent in the offering. HealthLynked, Corp. (NASDAQ: “HLYK”) executed a $2 million registered direct...
You must be a Standard 1 Year member to access this content.
Pestalozzi advised H.C. Wainwright LLC on the deal, while VISCHER advised Relief Therapeutics. RELIEF THERAPEUTICS Holding AG. a biopharmaceutical company seeking to provide patients therapeutic relief from...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Bird & Bird, McDermott Will & Emery, advised on the matter. Bird & Bird advised Pixium Vision SA with a team including Emmanuelle Porte...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering. Theravance Biopharma, Inc. executed its $100.5 million public offering of ordinary shares. Theravance Biopharma’s ordinary shares are listed on the Nasdaq...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Janux Therapeutics, Inc. on the deal, while Latham & Watkins LLP represented the underwriters. Janux Therapeutics, Inc., a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Edwin Coe advised H.C. Wainwright & Co. on the deal. H.C. Wainwright & Co. acted as placement agent, in a private placement of 53.3m of Eurasia Mining...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling advised the underwriters in the offering. Mazanti advised Y-mAbs Therapeutics.r Y-mAbs Therapeutics, Inc. executed its 2,804,878 shares of common stock at a public offering...
You must be a Standard 1 Year member to access this content.
